Scroll to Explore

Many clinicians have to make critical blood therapy decisions based on the limited snapshots provided by traditional tests – tests that simply weren’t designed to provide them with the timely, relevant and comprehensive results they need (1-4). Effective hemostasis management requires that physicians have the most complete information to make decisions on how to best maintain and/or restore a patient’s coagulation equilibrium.

Literature and ongoing trials have shown by adding the TEG® Hemostasis Analyzer System to your clinical practice and blood management program, you can help predict and manage coagulopathy (3-8), help assess the risk for re-operation (9-10), and realize cost savings through the reduction of unnecessary blood component transfusions (10-11).